SCHEMBL11535663

SCHEMBL11535663

CNNc1nnc(-c2ccc(Cl)cc2)c(-c2ccc(Cl)cc2)n1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADORA2A P29274 2/20 0.45
ADORA1 P30542 2/20 0.45
LMNA P02545 5/20 0.42
GAA P10253 3/20 0.42
KDM4E B2RXH2 2/20 0.42
SMN1; SMN2 Q16637 2/20 0.42
ALDH1A1 P00352 1/20 0.42
L3MBTL1 Q9Y468 1/20 0.41
RXFP1 Q9HBX9 3/20 0.40
NPC1 O15118 3/20 0.40
RAB9A P51151 3/20 0.40
MEN1 O00255 3/20 0.40
KMT2A Q03164 3/20 0.40
CYP1A2 P05177 2/20 0.40
CYP2C9 P11712 2/20 0.40
CYP2C19 P33261 2/20 0.40
NPSR1 Q6W5P4 2/20 0.40
POLB P06746 2/20 0.38
PTGES O14684 1/20 0.36
MYC P01106 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11862459 0.71 ADORA2A (0.50) ADORA2AADORA1LMNAGAAKDM4E
SCHEMBL2320673 0.70 SMN1; SMN2 (0.57) ADORA1LMNAKDM4ESMN1; SMN2ALDH1A1
SCHEMBL13108726 0.70 NPSR1 (0.59) ADORA2AADORA1LMNAGAAKDM4E
SCHEMBL10845179 0.69 SMN1; SMN2 (0.36) ADORA2AADORA1LMNAGAAKDM4E
SCHEMBL10845664 0.69 ADORA1 (0.37) ADORA2AADORA1LMNAGAAKDM4E
SCHEMBL11864615 0.68 ADORA2A (0.47) ADORA2AADORA1LMNAGAAKDM4E
SCHEMBL10811365 0.68 ADORA2A (0.47) ADORA2AADORA1LMNAGAAKDM4E
SCHEMBL10810257 0.68 RAB9A (0.43) ADORA2AADORA1LMNAGAAKDM4E
SCHEMBL10812119 0.68 NPSR1 (0.68) ADORA2AADORA1LMNAGAAKDM4E
SCHEMBL11338853 0.68 ADORA1 (0.47) ADORA2AADORA1LMNAGAAKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4157392-A HYPOTENSIVE AGENTS, ANTIINFLAMMATORY AGENTS, ANALGESICS, ANTIPYRETICS AND NERVOUS SYSTEM EFFECTS DIAMOND SHAMROCK CORPORATION (US) 1979-06-05 US claimed